These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Cohen H; Werring DJ; Chandratheva A; Mittal P; Devreese KMJ; Isenberg DA; J Thromb Haemost; 2023 Oct; 21(10):2963-2976. PubMed ID: 37391096 [TBL] [Abstract][Full Text] [Related]
3. Use of direct oral anticoagulants in antiphospholipid syndrome. Cohen H; Efthymiou M; Isenberg DA J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic treatment for stroke associated with antiphospholipid antibodies. Arachchillage DR; Machin SJ; Cohen H Expert Rev Hematol; 2014 Apr; 7(2):169-72. PubMed ID: 24606388 [TBL] [Abstract][Full Text] [Related]
5. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Muscal E; Brey RL Curr Rheumatol Rep; 2008 Jan; 10(1):67-73. PubMed ID: 18457615 [TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and potential treatment of antiphospholipid syndrome-related mainly on ischemic stroke]. Okuma H; Kitagawa Y Brain Nerve; 2013 Nov; 65(11):1319-32. PubMed ID: 24200610 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome - an update. Linnemann B Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764 [TBL] [Abstract][Full Text] [Related]
8. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin. Markousis-Mavrogenis G; Sfikakis PP; Mavrogeni SI; Tektonidou MG Clin Rheumatol; 2021 Jul; 40(7):2559-2568. PubMed ID: 33196982 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome and the brain in pediatric and adult patients. Muscal E; Brey RL Lupus; 2010 Apr; 19(4):406-11. PubMed ID: 20353978 [TBL] [Abstract][Full Text] [Related]
11. Neurologic Manifestations of the Antiphospholipid Syndrome - an Update. Leal Rato M; Bandeira M; Romão VC; Aguiar de Sousa D Curr Neurol Neurosci Rep; 2021 Jun; 21(8):41. PubMed ID: 34125304 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766 [TBL] [Abstract][Full Text] [Related]
14. The management of stroke in antiphospholipid syndrome. Panichpisal K; Rozner E; Levine SR Curr Rheumatol Rep; 2012 Feb; 14(1):99-106. PubMed ID: 22109663 [TBL] [Abstract][Full Text] [Related]
19. Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome. Mustafa R Curr Neurol Neurosci Rep; 2022 Oct; 22(10):589-600. PubMed ID: 36040563 [TBL] [Abstract][Full Text] [Related]
20. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment]. van Mens TE; Middeldorp S; Coppens M Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]